Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study

Journal article

Peer reviewed

S.E. Waggoner, J. Java, B.J. Monk, H. Michael, R.T. Penson, M.M. Leitao, R.L. Coleman, R.S. Mannel, A. Oaknin and K.S. Tewari

Gynecologic oncology, Vol.137, pp.143-144

04/01/2015

Metrics

1 Record Views

Title: Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): An NRG Oncology/Gynecologic Oncology Group study
Creators: S.E. Waggoner - University Hospitals Case Medical Center
J. Java - Gynecologic Oncology Group
B.J. Monk - University of Arizona
H. Michael - Indiana University
R.T. Penson - Massachusetts General Hospital
M.M. Leitao - Memorial Sloan Kettering Cancer Center
R.L. Coleman - The University of Texas MD Anderson Cancer Center
R.S. Mannel - University of Oklahoma Health Sciences Center
A. Oaknin - Spanish Ovarian Cancer Research Group
K.S. Tewari - University of California, Irvine Medical Center
Publication Details: Gynecologic oncology, Vol.137, pp.143-144
Publisher: Elsevier Inc
Identifiers: 991005969041002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article